Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024


#186329

172pages

Transparency Market Research

$ 5795

In Stock

Global Drugs of Abuse Testing Market: Scope and Methodology

This report on the global drugs of abuse testing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global drugs of abuse testing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

 A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global drugs of abuse testing market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of product and product features of different types. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing demand for drug abuse testing in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Drugs of Abuse Testing Market: Segmentation

Based on product type, the global drugs of abuse testing market has been segmented three major sub segments namely, analyzers, rapid testing devices and consumables. The analyzers product type segment is further sub – segmented into immunoassay analyzers, chromatographic devices and breath analyzers. The rapid testing devices product type segment is further sub segmented into urine testing devices and oral fluid testing devices. The consumables product type segment is further sub – segmented into fluid collection devices and others. The market has been further studied from the point of view of sample type.

Based on sample type, the market has been segmented into saliva, breath, urine, blood, hair & sweat. On the basis of testing type, the market has been segmented into pain management testing, criminal justice testing and work place screening. Based on the end users the market is categorized into hospitals, diagnostics laboratories, on-the-spot testing and forensic laboratories.

Drugs of Abuse Testing Market: Geographical Outlook

Geographically, the global drugs – of – abuse testing market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, GCC Countries, South Africa, Brazil, and Mexico.

Key Players Mentioned in the Report are:

The report also profiles major players in the drugs of abuse testing market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Alere Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthcare, Express Diagnostics International Inc. and Shimadzu Corporation.

The global drugs of abuse testing market has been segmented as follows:

Global Drugs of Abuse Testing Market, by Product Type

  •  Analyzers
  • Immunoassays Analyzers
  • Chromatographic Devices
  • Breath Analyzers
  • Rapid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Fluid Collection Devices
  • Others

Global Drugs of Abuse Testing Market, by Sample Type

  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

Global Drugs of Abuse Testing Market, by Testing Type

  • Pain Management Testing
  • Criminal Justice Testing
  • Work Place Screening

Global Drugs of Abuse Testing Market, by End User

  • Hospitals
  • Diagnostics Laboratories
  • On-the-spot Testing
  • Forensic Laboratories

Global Drugs of Abuse Testing Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

 

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Drugs – of – Abuse Testing Market  

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Regulatory Scenario
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.4.4. Trends
4.5. Market Revenue Projections (US$ Mn)
4.6. Market Outlook
4.7. Porter’s Five Forces Analysis 
4.8. Value Chain Analysis
4.9. Technology Assessment 
4.10. Global Demand and Supply Scenario 

5. Global Drugs – of – Abuse Testing  Market Analysis and Forecast, By Product Type
5.1. Introduction 
5.2. Product Comparison Matrix 
5.3. Market Revenue Share (US$) and Attractiveness Analysis, By Product Type
5.4. Market Size (US$ Mn) Forecast, By  Product Type  
5.4.1. Analyzers 
5.4.1.1. Immunoassay Analyzers
5.4.1.2. Chromatographic Devices
5.4.1.3. Breath Analyzers
5.4.2. Rapid Testing Devices
5.4.2.1. Urine Testing Devices 
5.4.2.2. Oral Fluid Testing Devices
5.4.3. Consumables
5.4.3.1. Fluid Collection Devices
5.4.3.2. Others

6. Global Drugs – of – Abuse Testing  Market Analysis and Forecast, By Sample Type
6.1. Introduction 
6.2. Market Revenue Share (US$) and Attractiveness Analysis, By Sample Type 
6.3. Market Size (US$ Mn) Forecast, By Sample Type  
6.3.1. Saliva
6.3.2. Breath
6.3.3. Urine
6.3.4. Blood
6.3.5. Hair & Sweat

7. GlobalDrugs - of - Abuse Testing  Market Analysis and Forecast, By Testing Type
7.1. Introduction 
7.2. Market Revenue Share (US$) and Attractiveness Analysis, By Testing Type 
7.3. Market Size (US$ Mn) Forecast, By Testing Type  
7.3.1. Pain Management Testing
7.3.2. Criminal Justice Testing
7.3.3. Work Place Screening

8. GlobalDrugs – of – Abuse Testing  Market Analysis and Forecast, By End User 
8.1. Introduction 
8.2. Market Revenue Share (US$) and Attractiveness Analysis, By End User 
8.3. Market Size (US$ Mn) Forecast, By End User  
8.3.1. Hospitals
8.3.2. Diagnostics Laboratories
8.3.3. On-the-spot Testing
8.3.4. Forensic Laboratories

9. GlobalDrugs – of – Abuse Testing  Market Analysis and Forecast, By Region 
9.1. Market Revenue Share (US$) and Attractiveness Analysis, By Region 
9.2. Market Size (US$ Mn) Forecast, By Region  
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East and Africa

10. North  Drugs – of – Abuse Testing Market Analysis and Forecast
10.1. Market Overview
10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
10.1.2. Testing Market Attractiveness Analysis, by Country
10.2. Market Value Share Analysis by Product Type  
10.2.1. Analyzers 
10.2.1.1. Immunoassay Analyzers
10.2.1.2. Chromatographic Devices
10.2.1.3. Breath Analyzers
10.2.2. Rapid Testing Devices
10.2.2.1. Urine Testing Devices 
10.2.2.2. Oral Fluid Testing Devices
10.2.3. Consumables
10.2.3.1. Fluid Collection Devices
10.2.3.2. Others Sub-mucosal Fibroids
10.3. Market Value Share Analysis by Sample Type  
10.3.1. Saliva
10.3.2. Breath
10.3.3. Urine
10.3.4. Blood
10.3.5. Hair & Sweat
10.4. Market Value Share Analysis by Testing Type  
10.4.1. Pain Management 
10.4.2. Criminal Justice Testing 
10.4.3. Work Place Screening
10.5. Market Value Share Analysis by End User  
10.5.1. Hospitals 
10.5.2. Diagnostics Laboratories
10.5.3. On – the – Spot Testing
10.5.4. Forensic Laboratories
10.6. Market Value Share Analysis by Country  
10.6.1. U.S.
10.6.2. Canada
10.7. Market Size (US$ Mn) Forecast
10.7.1. By Product Type
10.7.2. By Sample Type
10.7.3. By Testing Type
10.7.4. By End User
10.7.5. By Country
10.8. Market Attractiveness Analysis 
10.8.1. By Product Type
10.8.2. By Sample Type
10.8.3. By Testing Type
10.8.4. By End User

11. Latin America  Drugs – of – Abuse Testing Market Analysis and Forecast
11.1. Market Overview
11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
11.1.2. Testing Market Attractiveness Analysis, by Country
11.2. Market Value Share Analysis by Product Type  
11.2.1. Analyzers 
11.2.1.1. Immunoassay Analyzers
11.2.1.2. Chromatographic Devices
11.2.1.3. Breath Analyzers
11.2.2. Rapid Testing Devices
11.2.2.1. Urine Testing Devices 
11.2.2.2. Oral Fluid Testing Devices
11.2.3. Consumables
11.2.3.1. Fluid Collection Devices
11.2.3.2. Others Sub-mucosal Fibroids
11.3. Market Value Share Analysis by Sample Type  
11.3.1. Saliva
11.3.2. Breath
11.3.3. Urine
11.3.4. Blood
11.3.5. Hair & Sweat
11.4. Market Value Share Analysis by Testing Type  
11.4.1. Pain Management 
11.4.2. Criminal Justice Testing 
11.4.3. Work Place Screening
11.5. Market Value Share Analysis by End User  
11.5.1. Hospitals 
11.5.2. Diagnostics Laboratories
11.5.3. On – the – Spot Testing
11.5.4. Forensic Laboratories
11.6. Market Value Share Analysis by Country  
11.6.1. Mexico
11.6.2. Brazil
11.6.3. Rest of Latin America
11.7. Market Size (US$ Mn) Forecast
11.7.1. By Product Type
11.7.2. By Sample Type
11.7.3. By Testing Type
11.7.4. By End User
11.7.5. By Country
11.8. Market Attractiveness Analysis 
11.8.1. By Product Type
11.8.2. By Sample Type
11.8.3. By Testing Type
11.8.4. By End User

12. Europe Drugs – of – Abuse Testing Market Analysis and Forecast
12.1. Market Overview
12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
12.1.2. Testing Market Attractiveness Analysis, by Country
12.2. Market Value Share Analysis by Product Type  
12.2.1. Analyzers 
12.2.1.1. Immunoassay Analyzers
12.2.1.2. Chromatographic Devices
12.2.1.3. Breath Analyzers
12.2.2. Rapid Testing Devices
12.2.2.1. Urine Testing Devices 
12.2.2.2. Oral Fluid Testing Devices
12.2.3. Consumables
12.2.3.1. Fluid Collection Devices
12.2.3.2. Others Sub-mucosal Fibroids
12.3. Market Value Share Analysis by Sample Type  
12.3.1. Saliva
12.3.2. Breath
12.3.3. Urine
12.3.4. Blood
12.3.5. Hair & Sweat
12.4. Market Value Share Analysis by Testing Type  
12.4.1. Pain Management 
12.4.2. Criminal Justice Testing 
12.4.3. Work Place Screening
12.5. Market Value Share Analysis by End User  
12.5.1. Hospitals 
12.5.2. Diagnostics Laboratories
12.5.3. On – the – Spot Testing
12.5.4. Forensic Laboratories
12.6. Market Value Share Analysis by Country  
12.6.1. U.K.
12.6.2. France
12.6.3. Germany
12.6.4. Italy
12.6.5. Spain
12.6.6. Russia
12.6.7. Rest of Europe
12.7. Market Size (US$ Mn) Forecast
12.7.1. By Product Type
12.7.2. By Sample Type
12.7.3. By Testing Type
12.7.4. By End User
12.7.5. By Country
12.8. Market Attractiveness Analysis 
12.8.1. By Product Type
12.8.2. By Sample Type
12.8.3. By Testing Type
12.8.4. By End User

13. APAC Drugs – of – Abuse Testing Market Analysis and Forecast
13.1. Market Overview
13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
13.1.2. Testing Market Attractiveness Analysis, by Country
13.2. Market Value Share Analysis by Product Type  
13.2.1. Analyzers 
13.2.1.1. Immunoassay Analyzers
13.2.1.2. Chromatographic Devices
13.2.1.3. Breath Analyzers
13.2.2. Rapid Testing Devices
13.2.2.1. Urine Testing Devices 
13.2.2.2. Oral Fluid Testing Devices
13.2.3. Consumables
13.2.3.1. Fluid Collection Devices
13.2.3.2. Others Sub-mucosal Fibroids
13.3. Market Value Share Analysis by Sample Type  
13.3.1. Saliva
13.3.2. Breath
13.3.3. Urine
13.3.4. Blood
13.3.5. Hair & Sweat
13.4. Market Value Share Analysis by Testing Type  
13.4.1. Pain Management 
13.4.2. Criminal Justice Testing 
13.4.3. Work Place Screening
13.5. Market Value Share Analysis by End User  
13.5.1. Hospitals 
13.5.2. Diagnostics Laboratories
13.5.3. On – the – Spot Testing
13.5.4. Forensic Laboratories
13.6. Market Value Share Analysis by Country  
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of APAC
13.7. Market Size (US$ Mn) Forecast
13.7.1. By Product Type
13.7.2. By Sample Type
13.7.3. By Testing Type
13.7.4. By End User
13.7.5. By Country
13.8. Market Attractiveness Analysis 
13.8.1. By Product Type
13.8.2. By Sample Type
13.8.3. By Testing Type
13.8.4. By End User

14. MEA Drugs – of – Abuse Testing Market Analysis and Forecast
14.1. Market Overview
14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
14.1.2. Testing Market Attractiveness Analysis, by Country
14.2. Market Value Share Analysis by Product Type  
14.2.1. Analyzers 
14.2.1.1. Immunoassay Analyzers
14.2.1.2. Chromatographic Devices
14.2.1.3. Breath Analyzers
14.2.2. Rapid Testing Devices
14.2.2.1. Urine Testing Devices 
14.2.2.2. Oral Fluid Testing Devices
14.2.3. Consumables
14.2.3.1. Fluid Collection Devices
14.2.3.2. Others Sub-mucosal Fibroids
14.3. Market Value Share Analysis by Sample Type  
14.3.1. Saliva
14.3.2. Breath
14.3.3. Urine
14.3.4. Blood
14.3.5. Hair & Sweat
14.4. Market Value Share Analysis by Testing Type  
14.4.1. Pain Management 
14.4.2. Criminal Justice Testing 
14.4.3. Work Place Screening
14.5. Market Value Share Analysis by End User  
14.5.1. Hospitals 
14.5.2. Diagnostics Laboratories
14.5.3. On – the – Spot Testing
14.5.4. Forensic Laboratories
14.6. Market Value Share Analysis by Country  
14.6.1. GCC Countries 
14.6.2. South Africa
14.6.3. Rest of MEA
14.7. Market Size (US$ Mn) Forecast
14.7.1. By Product Type
14.7.2. By Sample Type
14.7.3. By Testing Type
14.7.4. By End User
14.7.5. By Country
14.8. Market Attractiveness Analysis 
14.8.1. By Product Type
14.8.2. By Sample Type
14.8.3. By Testing Type
14.8.4. By End User

15. Competition Landscape
15.1. Market Player – Competition Matrix 
15.2. Market Share Analysis By Company (2015)
15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.3.1. F. Hoffmann La-Roche Ltd
15.3.1.1. Company Details
15.3.1.2. Company Description
15.3.1.3. Business Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Siemens Healthineers (Siemens AG)
15.3.2.1. Company Details
15.3.2.2. Company Description
15.3.2.3. Business Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Thermo Fisher Scientific, Inc.
15.3.3.1. Company Details
15.3.3.2. Company Description
15.3.3.3. Business Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Alere, Inc.
15.3.4.1. Company Details
15.3.4.2. Company Description
15.3.4.3. Business Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Shimadzu Corporation
15.3.5.1. Company Details
15.3.5.2. Company Description
15.3.5.3. Business Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Laboratory Corporation of America Holdings
15.3.6.1. Company Details
15.3.6.2. Company Description
15.3.6.3. Business Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Drägerwerk AG & Co. KGaA
15.3.7.1. Company Details
15.3.7.2. Company Description
15.3.7.3. Business Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Express Diagnostics International Inc.
15.3.8.1. Company Details
15.3.8.2. Company Description
15.3.8.3. Business Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview

Table 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Product Type, 2016–2024 (1/2)
Table 2: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Sample Type, 2016–2024
Table 3: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Testing Type, 2016–2024
Table 4: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 5: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Region, 2016–2024
Table 6: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 7: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 8: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 9: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 10: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 11: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 12: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 13: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 14: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 15: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 16: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 (1/2)
Table 17: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 18: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 19: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 20: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 21: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 22: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 23: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 24: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 25: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 26: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 27: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 28: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 29: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 30: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024

 

Figure 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, 2016–2024
Figure 2: Global Drug of Abuse Testing Market Value Share By Product Type (2016)
Figure 3: Global Drug of Abuse Testing Market Value Share By Sample Type (2016)
Figure 4: Global Drug of Abuse Testing Market Value Share By Testing Type (2016)
Figure 5: Global Drug of Abuse Testing Market Value Share By End User (2016)
Figure 6: Global Drug of Abuse Testing Market Value Share By Region (2016)
Figure 7: Global Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 8: Global Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 9: Global Analyzers Market Revenue (US$ Mn) 2016–2024
Figure 10: Global Rapid Testing Devices Market Revenue (US$ Mn), 2016–2024
Figure 11: Global Consumables Market Revenue (US$ Mn) 2016–2024
Figure 12: Global Drug of Abuse Testing Market Value Share Analysis By Sample Type, 2016 and 2024
Figure 13: Global Drug of Abuse Testing Market Attractiveness Analysis By Sample Type, 2015
Figure 14: Global Saliva Market Revenue (US$ Mn) 2016–2024
Figure 15: Global Breath Market Revenue (US$ Mn), 2016–2024
Figure 16: Global Urine Market Revenue (US$ Mn), 2016–2024
Figure 17: Global Blood Market Revenue (US$ Mn), 2016–2024
Figure 18: Global Hair and Sweat Market Revenue (US$ Mn), 2016–2024
Figure 19: Global Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 20: Global Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 21: Global Pain Management Testing Market Revenue (US$ Mn) 2016–2024
Figure 22: Global Criminal Justice Testing Market Revenue (US$ Mn), 2016–2024
Figure 23: Global Work Place Screening Market Revenue (US$ Mn) 2016–2024
Figure 24: Global Drug of Abuse Testing Market Value Share Analysis, by End User, 2016 and 2024
Figure 25: Global Drug of Abuse Testing Market Attractiveness Analysis, by End User, 2015
Figure 26: Global Hospital Market Revenue (US$ Mn) 2016–2024
Figure 27: Global Diagnostic Laboratories Market Revenue (US$ Mn), 2016–2024
Figure 28: Global On-the-spot Testing Market Revenue (US$ Mn) 2016–2024
Figure 29: Global Forensic Laboratories Market Revenue (US$ Mn), 2016–2024
Figure 30: Global Drug of Abuse Testing Market Value Share Analysis By Region, 2016 and 2024
Figure 31: Global Drug of Abuse Testing Market Attractiveness Analysis, By Region, 2015
Figure 32: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 33: North America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 34: North America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 35: North America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 36: North America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 37: North America Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 38: North America Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 39: North America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 40: North America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 41: North America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 42: North America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 43: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 44: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 45: Latin America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 46: Latin America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 47: Latin America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 48: Latin America Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 49: Latin America Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 50: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 51: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 52: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 53: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 54: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 55: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 56: Europe Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 57: Europe Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 58: Europe Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 59: Europe Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 60: Europe Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 61: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 62: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 63: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 64: Europe Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 65: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 66: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 67: APAC Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 68: APAC Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 69: APAC Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 70: APAC Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 71: APAC Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 72: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 73: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 74: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 75: APAC Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 76: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 77: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 78: MEA Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 79: MEA Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 80: MEA Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 81: MEA Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 84: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 85: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 86: MEA Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 87: Global Drugs – of – Abuse Testing Market, Company Share Analysis, 2015
Figure 81: MEA Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015